Progress towards the discovery of orally active thrombin inhibitors

Current Medicinal Chemistry

Volumn 5, Issue 6, 1998, Pages 457-468

  Menear, Keith ^a  

^a Novartis Horsham Research Center   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 AMINO 6 METHYL 5 PYRIDINYLMETHYLAMINOCARBONYLMETHYL) 3 BENZYLSULFONAMIDO 6 METHYL 2 PYRIDINONE; 1 (6 AMINO 2 METHYL 3 PYRIDINYLMETHYLAMINOCARBONYLMETHYL) 3 PHENETHYLAMINO 6 METHYL 2 PYRAZINONE; ACETYL DEXTRO PHENYLALANYLPROLYLBOROARGININE; CGH 728; DESULFATOHIRUDIN; LB 30057; NAPSAGATRAN; PEFA 1286; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

BLOOD CLOTTING; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; ANTITHROMBINS; HUMANS;

EID: 0031771350     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Takada, Akikazu; Takada, Yumiko; Urano, Tetsumei. The physiological aspects of fibrinolysis. Thromb. Res. 1994, 76(1), 1-31.
2. Kaiser Brigitte. Thrombin and factor Xa inhibitors. Drugs of the Future. 1998, 23(4), 423-436.
3. Turpie, Alexander G. G.; Weitz, Jeffrey I.; Hirsh, Jack. Advances in antithrombotic therapy: novel agents. Thromb. Haemostasis 1995, 74(1), 565-71.
4. Fenton, J. W., II; Ofosu, F. A.; Moon, D. G.; Maraganore, J. M. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagulation Fibrinolysis 1991, 2(1), 69-75.
5. Ammar, H. O.; Ghorab, M.; El-Nahhas, S. A.; Makram, T. S. Improvement of the biological performance of oral anticoagulant drugs. Part 1. Warfarin. Pharmazie 1997, 52(8), 627-631.
6. Hirsh, J. Heparins. Fibrinolysis 1995, 9(Suppl. 1), 66-8.
7. Fareed, Jawed; Walenga, Jeanine M.; Hoppensteadt, Debra; Ahsan, Ahmed; Murphy, Rosemary; Weber, Stephanie; Pifarre, Roque. Pharmacological profile of low molecular weight heparins: implications in prophylaxis and the treatment of thrombotic disorders. Low Mol. Weight Heparins Clin. Pract. 1992, 63-84. Editor(s): Doutremepuich, Christian. Publisher: Dekker, New York, N. Y.
8. Kimball, S. D. Challenges in the development of orally bioavailable thrombin active site inhibitors. Blood Coagulation Fibrinolysis 1995, 6(6), 511-19.
9. Ripka, William C.; Vlasuk, George P. Antithrombotics/serine proteases. Annu. Rep. Med. Chem. 1997, 32, 71-89.
10. Freedman M. D. Oral Anticoagulants. Ther. Rev. 1992, 32, 196-209
11. Serlin, M. J.; Breckenridge, A. M. Drug interactions with warfarin. Drugs 1983, 25(6), 610-20.
12. Hamilton, Harriet W.; Steinbaugh, Bruce A.; Stewart, Barbra H., Chan, O. Helen; Schmid, Heidi L.; Schroeder, Richard; Ryan, Michael J.; Keiser, Joan; Taylor, Michael D.; et al. Evaluation of Physicochemical Parameters Important to the Oral Bioavailability of Peptide-like Compounds: Implications for the Synthesis of Renin Inhibitors. J. Med. Chem. 1995, 38(9), 1446-55.
13. Boyd, Steven A.; Fung, Anthony K. L.; Baker, William R.; Mantei, Robert A.; Armiger, Yoek Lin; Stein, Herman H.; Cohen, Jerome; Egan, David A.; Barlow, Jennifer L.; et al. C-Terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties. J. Med. Chem. 1992, 35(10), 1735-46.
14. Boyd, Steven A.; Fung, Anthony K. L.; Baker, William R.; Mantei, Robert A.; Stein, Herman H.; Cohen, Jerome; Barlow, Jennifer L.; Klinghofer, Vered; Wessale, Jerry L.; et al. Nonpeptide Renin Inhibitors with Good Intraduodenal Bioavailability and Efficacy in Dog. J. Med. Chem. 1994, 37(19), 2991-3007.
15. Samanen, James; Wilson, Glynn; Smith, Philip L.; Lee, Chao-Pin; Bondinell, William; Ku, Thomas; Rhodes, Gerald; Nichols, Andrew. Chemical approaches to improve the oral bioavailability of peptidergic molecules. J. Pharm. Pharmacol. 1996, 48(2), 119-35.
16. Karls, Michael S.; Rush, Bob D.; Wilkinson, Karen F.; Vidmar, Thomas J.; Burton, Philip S.; Ruwart, Mary J. Desolvation energy: a major determinant of absorption, but not clearance, of peptides in rats. Pharm. Res. 1991, 8(12), 1477-81.
17. Conradi, Robert A.; Hilgers, Allen R.; Ho, Norman F. H.; Burton, Philip S. The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res. 1992, 3(3), 435-9.
18. Smith, Amos B., III; Hirschmann, Ralph; Pasternak, Alexander; Akaishi, Ryouichi; Guzman, Mark C.; Jones, David R.; Keenan, Terence P.; Sprengeler, Paul A.; Darke, Paul L.; et al. Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transport. J. Med. Chem. 1994, 37(2), 215-18.
19. von Geldern, Thomas W.; Hoffman, Daniel J.; Kester, Jeffrey A.; Nellans, Hugh N.; Dayton, Brian D.; Calzadilla, Samuel V.; Marsh, Kennan C.; Hernandez, Lisa; Chiou, William; et al. Azole Endothelin Antagonists. 3. Using D log P as a Tool To Improve Absorption. J. Med. Chem. 1996, 39(4), 982-91.
20. Chan, O. Helen; Stewart, Barbra H. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discovery Today 1996, 7(11), 461-473.
21. Smith, Dennis A.; Jones, Barry C.; Walker, Donald K. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics. Med. Res. Rev. 1996, 16(3), 243-266.
22. Rekker, R. F.; ter Laak, A. M.; Mannhold, R. On the reliability of calculated log P-values: Rekker, Hansch/Leo and Suzuki approach. Quant. Struct.-Act. Relat. 1993, 12(2), 152-7.
23. Waterbeemd H, Lipophilicty in drug Action and Toxicology, Ed R Mannhold VCH 1996, ISBN 3-527-29383-3
24. Seiler P., Eur. J. Med. Chem-Chimica Theripeutica. 1974, 9, 473-479
25. Eckhardt, Uta; Stueber, Werner; Dickneite, Gerhard; Reers, Martin; Petzinger, Ernst. First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver. Interaction with bile acid transport systems. Biochem. Pharmacol. 1996, 52(1), 85-96.
26. Hoyle, William; Howarth, Graham Arton; Brundish, Derek Edward; Kane, Peter Daniel; Walker, Clive Victor; Hayler, Judy; Fullerton, Joseph David; Smith, Garric Paul; Wathey, William Bernard; et al. Preparation of arylsulfonylamino acid amide trypsin and thrombin inhibitors. WO 9629327 A1 960926.
27. Hilpert, Kurt; Ackermann, Jean; Banner, David W.; Gast, Alain; Gubernator, Klaus; Hadvary, Paul; Labler, Ludvik; Mueller, Klaus; Schmid, Gerard; et al. Design and Synthesis of Potent and Highly Selective Thrombin Inhibitors. J. Med. Chem. 1994, 37(23), 3889-901.
28. Reilly, T. M.; Knabb, R. M.; Hassell, S. M.; Bozarth, J. M.; Forsythe, M. S ; Mayo, M. C.; Racanelli, A. L.; Mousa, S. A. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin. Blood Coagulation Fibrinolysis 1992, 3(5), 513-17.
29. Deadman, John J.; Elgendy, Said; Goodwin, Christopher A.; Green, Donovan; Baban, Jehan A.; Patel, Geeta; Skordalakes, Emmanuel; Chino, Naoyoshi; Claeson, Goran; et al. Characterization of a Class of Peptide Boronates with Neutral P1 Side Chains as Highly Selective Inhibitors of Thrombin. J. Med. Chem. 1995, 38(9), 1511-22.
30. Conrad, Kenneth A. Clinical pharmacology and drug safety: Lessons from hirudin. Clin. Pharmacol. Ther. (St. Louis) 1995, 58(2), 123-6.
31. Das, Jagabandhu; Kimball, S. David. Thrombin active site inhibitors. Bioorg. Med. Chem. 1995, 3(8), 999-1007.
32. Turpie, Alexander G. G.; Weitz, Jeffrey I.; Hirsh, Jack. Advances in antithrombotic therapy. novel agents. Thromb. Haemostasis 1995, 74(1), 565-71.
33. Brady, S. F.; Lewis, S. D., Colton, C. D.; Stauffer, K. J.; Sisko, J. T.; Ng, A. S.; Homnick, C. F ; Bogusky, M. J.; Shafer, J. A ; et al. Development of highly potent and selective a-keto carbonyl thrombin inhibitors with novel P1 side chains: Synthesis and biological profile of L-370,518. Pept.: Chem., Struct. Biol , Proc. Am. Pept. Symp., 14th 1996, 331-333. Editor(s): Kaumaya, Pravin T. P.; Hodges, Robert S. Publisher: Mayflower Scientific, Kingswinford, UK.
34. Lewis, Sidney D.; Lucas, Bobby J.; Brady, Stephen F.; Sisko, John T.; Cutrona, Kellie J.; Sanderson, Philip E. J.; Freidinger, Roger M.; Mao, Shi-Shan; Gardell, Stephen J.; Shafer, Jules A. Characterization of the two-step pathway for inhibition of thrombin by a-ketoamide transition state analogs. J. Biol. Chem. 1998, 273(9), 4843-4854.
35. Altenburger, Jean Michel; Lassalle, Gilbert. Derivatives of 1-oxo-2-(phenylsulfonylamino)-pentylpiperidine, their preparation and therapeutic use. Eur. Pat. Appl., EP 718307 A2.
36. Misra, Raj N.; Kelly, Yolanda F.; Brown, Barbel R., Roberts, Daniel G. M.; Chong, Saeho; Seiler, Steven M. Argatroban analogs: synthesis, thrombin inhibitory activity and cell permeability of aminoheterocyclic guanidine surrogates. Bioorg. Med. Chem. Lett. 1994, 4(18), 2165-70.
37. Conradi, Robert A.; Hilgers, Allen R.; Ho, Norman F. H.; Burton, Philip S. The influence of peptide structure on transport across Caco-2 cells. Pharm. Res. 1991, 8(12), 1453-60
38. Von Der Saal, Wolfgang; Heck, Reinhard; Leinert, Herbert; Poll, Thomas, Stegmeier, Karlheinz; Michel, Helmut. Preparation of 4-[sulfonamido-, sulfamoyi-, and sulfonyl(oxy)phenoxyethylamino]pyridines and analogs as thrombin inhibitors. PCT Int. Appl., 103 pp. CODEN: PIXXD2. WO 9420467 A1 940915.
39. Heckel, Armin; Sauter, Robert; Psiorz, Manfred; Binder, Klaus; Mueller, Thomas; Zimmermann, Rainer. Preparation of benzimidazolylalaninamides as antithrombotics. Eur. Pat. Appl., 37 pp. CODEN: EPXXDW. EP 555824 A1 930818.
40. Brundish, Derek Edward, Kane, Peter Daniel; Walker, Clive Victor; Menear, Keith Allan; Le Grand, Darren Mark; Allen, Mark Christopher; Hayler, Judy D.; Herold, Peter; Butler, Paul Ian; Fullerton, Joseph Dawson; Smith, Garrick Paul; Wathey, William Bernard; Cockcroft, Xiao-Ling; Hatto, Julia Doris Ida. Preparation of N-(a-carboxy-a-benothiazolylmethyl)tetrahydroquinolinesulfonamides as inhibitors of trypsin and thrombin. Brit. UK Pat. Appl., GB 2312674 A1.
41. Tucker, Thomas J.; Lumma, William C ; Lewis, S. Dale; Gardell, Stephen J.; Lucas, Bobby J.; Baskin, Elizabeth P.; Woltmann, Richard; Lynch, Joseph J.; Lyle, Elizabeth A.; Appleby, Sandra D., Chen, I-Wu; Dancheck, Kimberley B.; Vacca, Joseph P. Potent Noncovalent Thrombin Inhibitors That Utilize the Unique Amino Acid D-Dicyclohexylalanine in the P3 Position. Implications on Oral Bioavailability and Antithrombotic Efficacy J. Med. Chem. 1997, 40(11), 1565-1569.
42. Tucker, Thomas J.; Lumma, William C.; Lewis, S. Dale; Gardell, Stephen J ; Lucas, Bobby J.; Sisko, Jack T.; Lynch, Joseph J.; Lyle, Elizabeth A ; Baskin, Elizabeth P.; Woltmann, Richard F.; Appleby, Sandra D.; Chen, I-Wu, Dancheck, Kimberley B.; Naylor-Olsen, Adel M.; Krueger, Julie A.; Cooper, Carolyn M.; Vacca, Joseph P. Synthesis of a Series of Potent and Orally Bioavailable Thrombin Inhibitors That Utilize 3,3-Disubstituted Propionic Acid Derivatives in the P3 Position. J. Med. Chem 1997, 40(22), 3687-3693.
43. Brady, Stephen F.; Stauffer, Kenneth J.; Lumma, William C.; Smith, Graham M.; Ramjit, Harri G.; Lewis, S. Dale; Lucas, Bobby J.; Gardell, Steven J.; Lyle, Elizabeth A.; Appleby, Sandra D.; Cook, Jacquelynn J.; Holahan, Marie A.; Stranieri, Maria T., Lynch, Joseph J., Jr.; Lin, Jiunn H., Chen, I.-Wu; Vastag, Kari; Naylor-Olsen, Adel M.; Vacca, Joseph P. Discovery and Development of the Novel Potent Orally Active Thrombin Inhibitor N-(9-Hydroxy-9-fluorenecarboxy)prolyl trans-4-Aminocyclohexylmethyl Amide (L-372,460): Coapplication of Structure-Based Design and Rapid Multiple Analog Synthesis on Solid Support. J. Med. Chem. 1998, 41(3), 401-406.
44. Tucker T. J., Book of Abstracts 214th American Chemical Society National Meeting, Las Vagas, Navada, USA, 7-11th September 1997.
45. Sanderson P. E. J., Book of Abstracts 214th American Chemical Society National Meeting, Las Vagas, Navada, USA, 7-11th September 1997.
46. Allen, Mike; Abel, Stuart M.; Barber, Christopher G.; Cussans, Nigel J.; Danilewicz, John C.; Ellis, David; Hawkeswood, Edward; Herron, Michelle; Holland, Stephen; Fox, David N. A.; James, Keith; Kobylecki, Ryszard J.; Overington, John P.; Pandit, Jayvardhan; Parmar, Harsukh; Fowling, Michael J.; Rance, David J.; Taylor, Wendy; Shepperson, Nicholas B. The discovery of UK-156,406 - an orally active thrombin inhibitor. Book of Abstracts, 215th ACS National Meeting, Dallas, March 29-April 2 1998, MEDI-200. Publisher: American Chemical Society, Washington, D. C.
47. Gempeler M., Wikstroem P., meier J., Imanidis G., Leuenberger H., Book of Abstracts 16th Congress of the International Society on Thrombosis and Haemostasis, Florence, Italy, 6-12th June 1997.